Study of domestic sugammadex for reversing muscle relaxants after lung surgery
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests a domestic version of sugammadex sodium (a drug that reverses muscle relaxants) after lung surgery. It aims to see how well it works to help you wake up and recover from anesthesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having elective lung surgery under general anesthesia with a breathing tube.
- Your health is stable (classified as ASA I, II, or III).
- You will receive the muscle relaxant rocuronium during surgery.
- You do not have severe liver, kidney, or lung disease, a bleeding disorder, a tracheal problem, or a known allergy to the study drugs.
- You are willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medicines used at the end of anesthesia to help you wake up safely and breathe on your own in the recovery room (PACU). It may help find which option works better for people having certain abdominal surgeries.
This trial tests two medicines that help reverse the muscle-relaxing drugs given to patients on breathing tubes in the intensive care unit. The goal is to see which one works better and faster so patients can wake up sooner.
This trial is testing how well a drug called sugammadex works at different doses to reverse the effects of muscle relaxants used during surgery in babies and children under 2 years old. It aims to find the safest and most effective dose for this age group.
This trial tests a new drug called HRS-9190 against a standard muscle relaxant (cisatracurium) given continuously through an IV during surgery. It aims to see if the new drug works as well and is safe for adults having planned surgery under general anesthesia.
This trial compares two muscle relaxants, rocuronium and cisatracurium, to see which causes fewer complications in people with chronic kidney disease (not on dialysis) who need general anesthesia. If you have kidney disease and are having surgery that requires a breathing tube, this study may help determine the safer drug for you.
This study compares a new muscle relaxant medication with a standard one to see how well they work for placing a breathing tube and maintaining muscle relaxation during surgery. It aims to find a safer or more effective option for patients undergoing general anesthesia.
Hear when a new Neuromuscular Blockade trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.